Fatty liver disease is an important cause of chronic liver disease affecting one quarter of the
world's population. There is debate regarding the most appropriate name and definition for …

Metabolic dysfunction-associated steatotic liver disease (MASLD), defined by the presence
of liver steatosis together with at least one out of five cardiometabolic factors, is the most …

NAFLD has a new name, metabolic dysfunction-associated steatotic liver disease
(MASLD)(pronounced ma-zuld). This new moniker was announced at the European …

The contribution of obesity and insulin resistance to nonalcoholic fatty liver disease (NAFLD)
is undeniable [1], and NAFLD has even been called the liver manifestation of metabolic …

Artificial intelligence (AI) is an increasingly relevant field in medicine as clinicians
incorporate technology into their daily practices. Nonalcoholic fatty liver disease (NAFLD) …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is
related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non …

The keystone of precision medicine in complex traits is to predict the onset and progression
of the disease. While there are different paths toward precision medicine, 1 genetic …

Non-alcoholic fatty liver disease (NAFLD) is a widespread contributor to chronic liver
disease globally. A recent consensus on renaming liver disease was established, and …

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases from steatosis (fat
accumulation in hepatocytes) to non-alcoholic steatohepatitis (NASH), which may further …

Letters to the Editor definition in clinical practice. The definition identifies patients with
significant hepatic fibrosis, 6, 7 cardiovascular disease, 8, 9 chronic kidney disease, 7, 10 …